These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32834018)

  • 21. Applying the Effective Programme Coverage framework to assess gaps in HIV prevention programmes for female sex workers and men who have sex with men in Nairobi, Kenya: findings from an expanded Polling Booth Survey.
    Bhattacharjee P; McClarty L; Isac S; Kimani J; Emmanuel F; Kabuti R; Kinyua A; Kombo BK; Owek C; Musyoki H; Kiplagat A; Arimi P; Shaw SY; Gandhi M; Malone S; Blanchard J; Garnett G; Becker ML
    J Int AIDS Soc; 2024 Jul; 27 Suppl 2(Suppl 2):e26240. PubMed ID: 38982888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
    Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
    Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    Capitine IPU; Macicame IB; Uanela AM; Bhatt NB; Yates A; Milazzo M; Nwoga C; Crowell TA; Michael NL; Robb ML; Jani IV; Kroidl A; Polyak CS; De Schacht C;
    PLoS One; 2021; 16(12):e0260126. PubMed ID: 34855790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.
    Kiwanuka N; Ssetaala A; Mpendo J; Wambuzi M; Nanvubya A; Sigirenda S; Nalutaaya A; Kato P; Nielsen L; Kaleebu P; Nalusiba J; Sewankambo NK
    J Int AIDS Soc; 2013 Jul; 16(1):18621. PubMed ID: 23880102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India.
    Newman PA; Chakrapani V; Weaver J; Shunmugam M; Rubincam C
    Vaccine; 2014 Oct; 32(44):5854-61. PubMed ID: 25173475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Men who have sex with men in Kisumu, Kenya: comfort in accessing health services and willingness to participate in HIV prevention studies.
    Okall DO; Ondenge K; Nyambura M; Otieno FO; Hardnett F; Turner K; Mills LA; Masinya K; Chen RT; Gust DA
    J Homosex; 2014; 61(12):1712-26. PubMed ID: 25089554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
    Koblin BA; Holte S; Lenderking B; Heagerty P
    J Acquir Immune Defic Syndr; 2000 Aug; 24(5):451-7. PubMed ID: 11035616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria.
    Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T
    BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.
    Hays RB; Kegeles SM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):164-71. PubMed ID: 10048904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil.
    de Souza CT; Lowndes CM; Szwarcwald CL; Sutmöller F; Bastos FI
    AIDS Care; 2003 Aug; 15(4):539-48. PubMed ID: 14509868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.
    Richardson S; Seekaew P; Koblin B; Vazquez T; Nandi V; Tieu HV
    PLoS One; 2017; 12(7):e0181702. PubMed ID: 28723970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).
    Underhill K; Guthrie KM; Colleran C; Calabrese SK; Operario D; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2109-2121. PubMed ID: 29327091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing Outcomes in HIV Prevention and Treatment Programs With Female Sex Workers and Men Who Have Sex With Men: Expanded Polling Booth Survey Protocol.
    Bhattacharjee P; McClarty LM; Kimani J; Isac S; Wanjiru Kabuti R; Kinyua A; Karakaja Okoyana J; Njeri Ndukuyu V; Musyoki H; Kiplagat A; Arimi P; Shaw S; Emmanuel F; Gandhi M; Becker M; Blanchard J
    JMIR Public Health Surveill; 2024 Jun; 10():e54313. PubMed ID: 38896842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.
    Farquhar C; John-Stewart GC; John FN; Kabura MN; Kiarie JN
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):491-5. PubMed ID: 16796522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
    Price MA; Rida W; Mwangome M; Mutua G; Middelkoop K; Roux S; Okuku HS; Bekker LG; Anzala O; Ngugi E; Stevens G; Chetty P; Amornkul PN; Sanders EJ
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):185-93. PubMed ID: 22227488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of sexual, physical and verbal assaults on men who have sex with men and female sex workers in coastal Kenya.
    Micheni M; Rogers S; Wahome E; Darwinkel M; van der Elst E; Gichuru E; Graham SM; Sanders EJ; Smith AD
    AIDS; 2015 Dec; 29 Suppl 3(0 3):S231-6. PubMed ID: 26562812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on willingness to participate in future preventive HIV vaccine trials.
    Suhadev M; Nyamathi AM; Swaminathan S; Venkatesan P; Raja Sakthivel M; Shenbagavalli R; Suresh A; Fahey JL
    Indian J Med Res; 2006 Dec; 124(6):631-40. PubMed ID: 17287550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.